Low vitamin D levels are associated with symptoms of depression in young adult males

Australian and New Zealand Journal of Psychiatry

Volumn 48, Issue 5, 2014, Pages 464-471

  Black, Lucinda J ^a   Jacoby, Peter ^a   Allen, Karina L ^a,b   Trapp, Gina S ^a   Hart, Prue H ^a   Byrne, Susan M ^b   Mori, Trevor A ^c   Beilin, Lawrence J ^c   Oddy, Wendy H ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

25 hydroxyvitamin D; cohort studies; epidemiology; Mental health; nutritional status

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ANXIETY; ARTICLE; AUSTRALIA; BLOOD SAMPLING; BODY MASS; CLINICAL ASSESSMENT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSION; DEPRESSION ANXIETY STRESS SCALE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; SEX DIFFERENCE; STRESS; YOUNG ADULT; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; MENTAL STRESS; SEX RATIO; VITAMIN D DEFICIENCY;

ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; SEX DISTRIBUTION; STRESS, PSYCHOLOGICAL; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84899848884     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867413512383     Document Type: Article

References (38)

1. Antony MM, Bieling PJ, Cox BJ, et al. Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. Psychological Assessment. 1998 ; 10: 176-181
2. Bertone-Johnson ER, Powers SI, Spangler L, et al. Vitamin D supplementation and depression in the Women's Health Initiative Calcium and Vitamin D Trial. American Journal of Epidemiology. 2012 ; 176: 1-13
3. Cass WA, Smith MP, Peters LE. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine. Annals of the New York Acadermy of Sciences. 2006 ; 1074: 261-271
4. Correale J, Ysrraelit MC, Gaitan MI. Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. The Journal of Immunology. 2010 ; 185: 4948-4958
5. Dean AJ, Bellgrove MA, Hall T, et al. Effects of vitamin D supplementation on cognitive and emotional functioning in young adults-a randomised controlled trial. PLoS One. 2011 ; 6 :
6. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure and Function. 2008 ; 213: 93-118
7. Dumville JC, Miles JN, Porthouse J, et al. Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women. The Journal of Nutrition Health and Aging. 2006 ; 10: 151-153
8. Eyles DW, Smith S, Kinobe R, et al. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. Journal of Chemical Neuroanatomy. 2005 ; 29: 21-30
9. Ganji V, Milone C, Cody MM, et al. Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. International Archives of Medicine. 2010 ; 3: 29
10. Garcion E, Wion-Barbot N, Montero-Menei CN, et al. New clues about vitamin D functions in the nervous system. Trends in Endocrinology and Metabolism. 2002 ; 13: 100-105
11. Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): Construct validity and normative data in a large non-clinical sample. British Journal of Clinical Psychology. 2005 ; 44: 227-239
12. Hoang MT, Defina LF, Willis BL, et al. Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clinic Proceedings. 2011 ; 86: 1050-1055
13. Hogberg G, Gustafsson SA, Hallstrom T, et al. Depressed adolescents in a case-series were low in vitamin D and depression was ameliorated by vitamin D supplementation. Acta Paediatrica. 2012 ; 101: 779-783
14. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism. 2011 ; 96: 1911-1930
15. Hoogendijk WJ, Lips P, Dik MG, et al. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Archives of General Psychiatry. 2008 ; 65: 508-512
16. Jamilian H, Bagherzadeh K, Nazeri Z, et al. Vitamin D, parathyroid hormone, serum calcium and phosphorus in patients with schizophrenia and major depression. International Journal of Psychiatry in Clinical Practice. 2013 ; 17: 30-34
17. Jorde R, Sneve M, Figenschau Y, et al. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. Journal of Internal Medicine. 2008 ; 264: 599-609
18. Kalueff AV, Keisala T, Minasyan A, et al. Behavioural anomalies in mice evoked by "Tokyo" disruption of the Vitamin D receptor gene. Neuroscience Research. 2006 ; 54: 254-260
19. Kjaergaard M, Joakimsen R, Jorde R. Low serum 25-hydroxyvitamin D levels are associated with depression in an adult Norwegian population. Psychiatry Research. 2011 ; 190: 221-225
20. Kjaergaard M, Waterloo K, Wang CE, et al. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. British Journal of Psychiatry. 2012 ; 201: 360-368
21. Lansdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl). 1998 ; 135: 319-323
22. Lee DM, Tajar A, O'Neill TW, et al. Lower vitamin D levels are associated with depression among community-dwelling European men. Journal of Psychopharmacology. 2011 ; 25: 1320-1328
23. Lovibond S, Lovibond PF Manual for the depression anxiety stress scales. Sydney: Psychology Foundation of Australia ; 1996 :
24. Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clinical Chemistry. 2005 ; 51: 1683-1690
25. McGrath J, Feron F, Eyles D, et al. Vitamin D: the neglected neurosteroid?. Trends in Neurosciences. 2001 ; 24: 570-572
26. Milaneschi Y, Shardell M, Corsi AM, et al. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. Journal of Clinical Endocrinology and Metabolism. 2010 ; 95: 3225-3233
27. Minasyan A, Keisala T, Lou YR, et al. Neophobia, sensory and cognitive functions, and hedonic responses in vitamin D receptor mutant mice. The Journal of Steroid Biochemistry and Molecular Biology. 2007 ; 104: 274-280
28. Nanri A, Mizoue T, Matsushita Y, et al. Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season. European Journal of Clinical Nutrition. 2009 ; 63: 1444-1447
29. Nashold FE, Spach KM, Spanier JA, et al. Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. The Journal of Immunology. 2009 ; 183: 3672-3681
30. Newnham JP, Evans SF, Michael CA, et al. Effects of frequent ultrasound during pregnancy: a randomised controlled trial. Lancet. 1993 ; 342: 887-891
31. Ng F, Trauer T, Dodd S, et al. The validity of the 21-item version of the Depression Anxiety Stress Scales as a routine clinical outcome measure. Acta Neuropsychiatrica. 2007 ; 19: 304-310
32. Pan A, Lu L, Franco OH, et al. Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese. Journal of Affective Disorders. 2009 ; 118: 240-243
33. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. British Journal of Psychiatry. 2011 ; 198: 357-364
34. Smith MP, Fletcher-Turner A, Yurek DM, et al. Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochemical Research. 2006 ; 31: 533-539
35. Suzuki M, Yoshioka M, Hashimoto M, et al. Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. American Journal of Clinical Nutrition. 2013 ; 97: 1004-1013
36. Tolppanen AM, Sayers A, Fraser WD, et al. The association of serum 25-hydroxyvitamin D3 and D2 with depressive symptoms in childhood-a prospective cohort study. Journal of Child Psychology and Psychiatry. 2012 ; 53: 757-766
37. van der Mei IA, Ponsonby AL, Dwyer T, et al. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. Journal of Neurology. 2007 ; 254: 581-590
38. Zhao G, Ford ES, Li C, et al. No associations between serum concentrations of 25-hydroxyvitamin D and parathyroid hormone and depression among US adults. British Journal of Nutrition. 2010 ; 104: 1696-1702